LamdaGen is a privately held Silicon Valley developer of nano-based biosensors that enable testing systems for highly sensitive and quantitative rapid diagnostics. The Company has harnessed discoveries of Localized Surface Plasmon Resonance (LSPR) the principles of which involve advanced physics, material science and light – and made simple its application in providing precise digital detection of biological and environmental targets for human diagnostic, companion animal, animal food stock, food safety and wearable performance monitoring and testing.
The Company’s patented nano-structured thin films change color in response to binding events occurring at their surface, thus providing simple tools to digitally quantify the presence of antigens and pathogens by simply measuring colors. The integration of LamdaGen’s micron-sized sensors with miniaturized optics and digital analysis brings unprecedented mobility, speed, sensitivity and ease of use to precision diagnostics.
LamdaGen’s L’AuRa digital sensing systems enable powerful monitoring across a broad range of categories including: cardio, endocrine, infectious, vector, food safety, veterinary, drugs of abuse and manufacturing contaminants.
Headquartered in Menlo Park, California, LamdaGen licenses its L’AuRa sensor technologies on an open architecture basis to companies for integration into their existing diagnostic/detection systems and consumables, or into advanced products in development.
For information, details and data email: info@LamdaGen.com